The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open-label, phase I/II trial of gemcitabine plus nab-paclitaxel with or without FG-3019 as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer.
 
Flavio G. Rocha
Consulting or Advisory Role - Covidien
 
Scott Helton
No Relationships to Disclose
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Amgen, Abbvie, Johnson and Johnson
Honoraria - Celgene
Research Funding - Fibrogen,Clovis,Immunomedics,Aduro, Theranostics